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Summary 
Coronary heart disease (CHD) and chronic obstructive pulmonary disease (COPD) are 
leading causes of morbidity, disability and mortality among Aboriginal and Torres Strait 
Islander people. These diseases develop at younger ages and progress faster in Indigenous 
Australians than in non-Indigenous Australians. This paper explores the prevalence of these 
conditions and their risk factors in the Indigenous population, as well as rates of 
hospitalisation and mortality from these 2 diseases. 
Prevalence of CHD and COPD is high in the Indigenous population 
The self-reported prevalence of CHD is higher among Indigenous than non-Indigenous 
adults across all age groups. Overall, CHD was 1.7 times higher for Indigenous males and 2.7 
times higher for Indigenous females than for their non-Indigenous counterparts in 2004–05. 
In 2012–13, approximately 4% of Indigenous adults reported having COPD, which was 2.5 
times the rate for non-Indigenous Australians. 
Prevalence of several risk factors is high in both the Indigenous and non-Indigenous 
populations  
In 2012–13, 44% of Indigenous adults smoked tobacco daily, 62% reported they were 
sedentary or engaged in low levels of exercise, and over two-thirds (69%) were overweight 
or obese. Indigenous adults were 2.6 times as likely to smoke tobacco daily as were 
non-Indigenous Australians. 
However, rates of smoking among Indigenous adults are declining 
The proportion of Indigenous adults who smoked daily fell from 51% in 2001 to 44% in  
2012–13.  
Hospitalisation rates for CHD and COPD are higher for Indigenous Australians 
The hospitalisation rate for CHD for Indigenous Australians was 2.4 times as high as the rate 
for non-Indigenous Australians between July 2010 and June 2012. For COPD hospitalisations 
over the same period, the Indigenous rate was 5 times as high as the non-Indigenous rate. 
Indigenous Australians are more likely to die from CHD and COPD than non-Indigenous 
Australians  
Indigenous Australians were twice as likely to die from CHD and nearly 3 times as likely to 
die from COPD as were non-Indigenous Australians during the period 2007–2011.  
However, CHD death rates are improving 
The rate of Indigenous deaths due to CHD fell by 36% between 2001 and 2011.  
And rates of chronic disease management are increasing 
Government programs tackling Indigenous chronic disease have led to increased uptake of 
MBS health checks, General Practitioner Management Plans, Team Care Arrangements and 
Closing the Gap prescriptions.   
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1 Introduction 
Chronic, non-communicable diseases (chronic diseases) are the largest contributor to the 
burden of disease experienced by Aboriginal and Torres Strait Islander Australians. Chronic 
diseases such as coronary heart disease (CHD), stroke, diabetes, chronic obstructive 
pulmonary disease (COPD), chronic kidney disease, cancers and arthritis are major causes of 
ill health, disability and mortality in the Indigenous population (AIHW 2011c; Thomas et al. 
2006).  
Chronic diseases tend to appear earlier, progress faster, present concurrently with other 
chronic diseases and cause more premature death in Indigenous Australians than in 
non-Indigenous Australians (AIHW 2011c; Panaretto et al. 2013). Underlying reasons for 
these differences include socioeconomic disadvantage among many Indigenous Australians 
in areas such as education, income and housing, and behavioural factors such as smoking, 
physical inactivity and poor nutrition. Cultural, historic and environmental factors also 
contribute to Indigenous Australians’ greater burden of disease. 
The Indigenous burden of disease, measured in terms of years of life lost due to premature 
death, as well as years of healthy life lost due to disability from disease, is greatly influenced 
by premature death. One measure of premature death is potential years of life lost (PYLL) 
due to disease or injury before a given age (for example, 75). The number of PYLL per 10,000 
people is higher among Indigenous Australians than other Australians. In other words, more 
deaths occur before the age of 75 in the Indigenous population than in the non-Indigenous 
population. About 80% of the difference (or gap) in PYLL between the 2 population groups 
in 2006 was attributed to chronic diseases (AIHW 2011c).  
While some chronic diseases may lead to sudden and unexpected death (for example, heart 
attacks associated with coronary heart disease), most of them have a gradual onset and 
persist throughout an individual’s life (Box 1.1).  
Box 1.1: Features and characteristics of chronic diseases 
Chronic diseases are health conditions or illnesses that persist over time and are 
characterised by: 
• a gradual onset during which there may be no symptoms 
• a prolonged course of illness with persistent effects that progress over time 
• complex causality, often associated with multiple risk factors 
• functional impairment or disability. 
Most chronic diseases are rarely cured completely and they do not usually resolve on their 
own. People can live for many years with chronic diseases; however, their quality of life can 
be significantly compromised through associated limitations to functioning and the need for 
assistance with daily activities. 
1.1 Policy context 
In recognition of the greater burden of disease experienced by Indigenous Australians, the 
Council of Australian Governments (COAG) in 2008 committed $1.6 billion over 4 years to 
close the health gap between Indigenous and non-Indigenous Australians within a 
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generation. As part of this commitment, the Australian Government dedicated $805.5 million 
to tackle chronic disease through the Indigenous Chronic Disease Package. The Package has 
3 main elements; tackling chronic disease risk factors, improving chronic disease 
management and follow-up care, and expanding and supporting the primary health-care 
workforce. The Indigenous Chronic Disease Package has since been consolidated into the 
Aboriginal and Torres Strait Islander Chronic Disease Fund. 
In March 2014, the Better Cardiac Care for Aboriginal and Torres Strait Islander People 
Forum was held in Sydney and was attended by health professionals and representatives 
from all Australian governments. This forum, which was instigated by the Australian Health 
Ministers’ Advisory Council, investigated why cardiac care outcomes differed for 
Indigenous people by focusing on primary care, acute care services, post-event care and 
coordination of care. 
1.2 Purpose and structure of this paper  
Epidemiology is the study of how much disease is present in a population and why. This 
paper explores the epidemiology of 2 chronic diseases in the Indigenous population: 
coronary heart disease and chronic obstructive pulmonary disease. See Box 1.2 for a 
discussion of why these health conditions were chosen, including the relative contribution 
these conditions make to Indigenous and non-Indigenous mortality.  
While much is known about the epidemiology of these diseases in the total Australian 
population, this paper presents the latest available data on the risk factors and prevalence of 
CHD and COPD in the Indigenous population, while also describing the hospitalisations and 
mortality caused by these conditions. It concludes by exploring how progress in CHD and 
COPD management has been evaluated using indicator-based monitoring. 
Box 1.2: Why is the epidemiology of CHD and COPD in the Indigenous population 
important? 
CHD and COPD were the 2 chronic diseases chosen for this paper because they contribute 
significantly to the burden of disease among Indigenous Australians, featuring in the top 3 
causes of burden of disease in 2003 along with mental disorders (Vos et al. 2007).  
Between July 2010 and June 2012, Indigenous Australians were hospitalised for CHD at a 
rate 2.4 times that for non-Indigenous Australians, and were hospitalised for COPD at a rate 
5 times that for non-Indigenous Australians.  
Coronary heart disease was the leading cause of Indigenous mortality in 2007–2011, 
responsible for 14% of all Indigenous deaths. Chronic obstructive pulmonary disease was 
the third leading cause of Indigenous mortality (after diabetes which was the second 
leading cause), responsible for 4% of all Indigenous deaths. However, this is likely to be an 
underestimation of its contributory role to death, as around 3 in 5 deaths involving COPD 
list it as an ‘associated’ cause of death, rather than the underlying or primary cause. If its 
total involvement in causing death is considered, the COPD death rate is 2.4 times as high 
as the underlying cause rate (AIHW 2012a).  
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Data sources 
The data sources used for this paper include the Australian Institute of Health and Welfare 
(AIHW) National Hospital Morbidity Database, the AIHW National Mortality Database, the 
Australian Bureau of Statistics (ABS) Australian Aboriginal and Torres Strait Islander Health 
Survey, the AIHW Healthy for Life program data collection and the AIHW national Key 
Performance Indicator data collection. See Appendix A for information on these data 
sources. 
The hospitalisation statistics presented in this paper are for all of Australia, except when time 
trend analyses are presented. In these instances, only the 6 jurisdictions with adequate 
Indigenous identification in their hospital reporting systems from 2004–05 are included in 
analyses: New South Wales, Victoria, Queensland, Western Australia, South Australia and 
the Northern Territory.  
The mortality data presented in this paper are analysed using the underlying (or primary) 
cause of death only and are from New South Wales, Queensland, Western Australia, South 
Australia and the Northern Territory combined. These jurisdictions are considered to have 
adequate levels of Indigenous identification in their mortality datasets from 2001 onwards. 
However, even in these jurisdictions, Indigenous status is not consistently reported on death 
registrations. This problem, combined with the relatively small size of the Indigenous 
population, means that the mortality estimates presented in this paper are associated with a 
degree of uncertainty.  
Neither mortality rates nor hospitalisation rates presented in this paper were adjusted for 
Indigenous under-identification. 
An additional issue to consider for interpreting trends in mortality is changes over time in 
Indigenous identification in death registrations data, as well as in the Census (which is used 
for the population denominator in the calculation of mortality rates). Trends presented in 
this paper should therefore be interpreted with caution. 
To account for differences in the age structure of the Indigenous and non-Indigenous 
populations, this paper presents age-specific rates and age-standardised rates throughout 
when comparing between these two populations. Appendix B provides information on how 
these statistics were calculated, and other technical points. 
 
 4 Coronary heart disease and chronic obstructive pulmonary disease in Indigenous Australians 
2 Coronary heart disease 
Coronary heart disease, also known as ischaemic heart disease, is the most common form of 
cardiovascular disease (CVD), followed by stroke. CHD is responsible for approximately half 
(49%) of all CVD deaths in Australia and stroke is responsible for 18% (AIHW 2011b).  
CHD can cause chest pain (angina) or a heart attack (Box 2.1). It develops over a long period, 
causes significant morbidity and is the largest single cause of mortality in Australia. The 
Indigenous burden of disease from CHD is high. It is the leading cause of mortality in the 
Indigenous population, responsible for 17% of years of life lost in males and 13% in females 
(Vos et al. 2007). It is also responsible for 4% of years of life lived with disability in both 
sexes.  
Box 2.1: Clinical presentation of coronary heart disease 
The 2 major clinical presentations of CHD are heart attack and angina, and they typically 
occur for the first time in middle age. Both involve inadequate blood flow (ischaemia) to the 
heart muscle, resulting from blockages in the coronary arteries, which supply blood to the 
heart. The blockages occur when fatty material called plaque is deposited on the coronary 
artery walls, in a process known as atherosclerosis. The plaque can restrict or block blood 
flow to the heart, posing serious cardiovascular complications. 
A heart attack (acute myocardial infarction) occurs when a coronary artery is suddenly 
blocked, partially or completely, by a blood clot. The blood clot forms when there is a 
rupture of the plaque deposited on the artery walls. If adequate flow is not restored quickly, 
the heart muscle begins to die, thereby increasing the chance of death.  
Angina is a chronic condition in which short episodes of chest pain can occur periodically 
when the heart has a temporary deficiency in its blood supply. Angina is generally not  
life-threatening on its own, although unstable angina is the more dangerous and less 
predictable form and is medically treated in a similar manner to heart attack.  
Health-care expenditure for cardiovascular disease is higher than for any other disease 
group in Australia, accounting for 12% of all allocated health-care expenditure. In  
2008–09, estimated expenditure for cardiovascular disease based primarily on hospital 
admitted patient services, out-of-hospital medical expenses and prescription 
pharmaceuticals was $7,605 million. More than one quarter of this amount (27%) was spent 
on CHD treatment and expenses (AIHW 2014b). 
2.1 Risk factors  
A variety of factors contribute to the development, progression and acute presentation of 
CHD, mostly through the process of atherosclerosis. The established risk factors for CHD are 
listed in Table 2.1 and include non-modifiable risk factors such as age and family history of 
CHD, as well as modifiable risk factors such as poor diet, physical inactivity and tobacco 
smoking. Other factors such as social determinants and environmental factors can also 
influence the development of CHD by affecting the conditions in which people live and 
work or the health-related decisions that they make (Kreatsoulas & Anand 2010). For 
example, some people live in passive-smoking households, and some people on low incomes 
may not be able to afford healthier foods.  
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Table 2.1: Known risk factors for CHD incidence, severity and mortality 
Non-modifiable 
Modifiable  May or may not be modifiable 
Biomedical Behavioural  Social determinants and environmental 
age excess body weight tobacco smoking  low socioeconomic status 
sex high blood pressure physical inactivity  psychosocial (including mental health issues) 
family history of CHD high blood cholesterol  poor diet  early life factors 
genetic factors high blood glucose excessive alcohol   environmental 
 low birthweight    
Sources: AIHW 2012b; Lichtman et al. 2008; Yusuf et al. 2001. 
The prevalence of several risk factors for chronic diseases is high in both the Indigenous and 
non-Indigenous populations. In 2012–13, 44% of Indigenous Australians aged 18 and over 
smoked tobacco daily, 3 in 5 (62%) were sedentary or engaged in low levels of exercise, and 1 
in 5 (20%) reported drinking at lifetime risky levels (Table 2.2). Furthermore, over two-thirds 
(69%) of the Aboriginal and Torres Strait Islander population were overweight or obese, 
which is associated with poor diet and physical inactivity.  
Table 2.2: Prevalence of selected CHD risk factors in Indigenous people aged 18 and over, 2012–13 
Risk factor Indigenous rate (%)(a) 
Rate ratio (Indigenous: 
non-Indigenous people)(b) 
Behavioural risk factors   
Sedentary/low level of exercise(c) 62 1.1 
Current daily smoker 44 2.6 
Inadequate daily fruit intake(d) 58 0.9(e) 
Inadequate daily vegetable intake(f) 95 0.9(e) 
Alcohol consumption exceeding:     
– single-occasion risk guidelines(g) 57 1.1 
– lifetime risk guidelines(h) 20 1.0 
Biomedical risk factors    
High blood pressure(i) 20 1.2 
Overweight/obese(j) 69 1.1 
High/very high levels of psychological distress 30 2.4 
(a)  Not adjusted for age. 
(b) Rate ratio calculated using proportions age-standardised to the 2001 Australian Estimated Resident Population. Data for non-Indigenous 
people are for 2011–12, from the Australian Health Survey 2011–13. 
(c) In non-remote areas, in the week prior to the survey. 
(d)  Defined as fewer than 2 serves of fruit per day. 
(e)  Based on age-standardised rates for people aged 15 and over. 
(f)  Defined as fewer than 5 serves of vegetables per day. 
(g)  Defined as more than 4 standard drinks on a single occasion (2009 NHMRC guidelines). 
(h)  Defined as more than 2 standard drinks per day on average (2009 NHMRC guidelines). 
(i)  Defined as blood pressure of 140/90 mmHg or higher. 
(j)  Defined as a Body Mass Index of 25 or over. 
Source: ABS 2013a.  
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After adjusting for differences in age structure, smoking rates in 2012–13 were 2.6 times as 
high among Indigenous as among non-Indigenous Australians, and rates of high/very high 
psychological distress were 2.4 times as high among Indigenous Australians (Table 2.2). 
Prevalence of other behavioural and biomedical risk factors—such as alcohol consumption, 
overweight/obesity, inadequate daily fruit and vegetable intake, and sedentary/low level of 
exercise—were fairly similar among the 2 populations. However, rates of obesity alone (that 
is, excluding those who were overweight) are higher in the Indigenous population, as are 
rates of sedentary levels of exercise (as opposed to low levels of exercise as well) (ABS 
2013a). 
Blood test results from the 2012–13 Australian Aboriginal and Torres Strait Islander Health 
Survey (AATSIHS) were unavailable at the time of publication. Data from the previous 
National Aboriginal and Torres Strait Islander Health Survey (NATSIHS), conducted in 
2004–05, show that the rates of elevated blood glucose reported by Indigenous adults were 3 
times as high as for non-Indigenous adults. However, the self-reported rates of high blood 
cholesterol were 60% lower among the Indigenous population, which may be due to lower 
rates of diagnosis (AIHW analysis of 2004–05 NATSIHS). 
Indigenous people are more disadvantaged than non-Indigenous people across a number of 
socioeconomic factors, including lower levels of household income, lower rates of year 12 
completion and higher rates of unemployment (AIHW 2013a). Analyses undertaken by the 
AIHW using the 2004–05 NATSIHS indicated that social determinants alone (including 
school and non-school education, employment status, overcrowding and household income) 
explained around one-third (31%) of the health gap between Indigenous and non-Indigenous 
Australians (AIHW 2014a forthcoming). 
A number of the risk factors for CHD mentioned above can be addressed by a mix of 
programs targeting individuals (for example, smoking cessation programs targeting 
Indigenous individuals within the primary health-care context), as well as by programs 
targeting the whole population (for example, mass advertising programs about alcohol 
consumption, diet and obesity). The relative effectiveness of these different approaches (that 
is, population-wide public health initiatives versus initiatives targeting individuals who seek 
health care) in reducing risk factors in the Indigenous population requires further 
exploration and more program evaluations to assess their impact. 
CHD risk factors over the life course  
Risk factors for developing coronary heart disease can present early in life, even in the foetal 
and infancy stages. For example, low birthweight, exposure to tobacco smoke and poor diet 
during childhood can make people more susceptible to developing CHD (AIHW 2012b). 
These risk factors have a relatively high prevalence in the Indigenous population. In 2011, 
13% of babies born to Indigenous mothers were of low birthweight (< 2,500 grams) 
compared with 6% of babies born to non-Indigenous mothers (Li et al. 2013). In addition, 
after adjusting for age differences, Indigenous women were 4 times as likely to smoke while 
pregnant as were non-Indigenous women in 2011 (Li et al. 2013). According to the 2012–13 
AATSIHS, about 93% of Indigenous children aged 5–17 consumed inadequate amounts of 
fruit and vegetables (ABS 2013a). However, this was similar to the proportion (95%) for all 
Australian children. 
Tobacco use, poor diet and physical inactivity—3 major behavioural risk factors for CHD—
can establish themselves in childhood and adolescence, and continue throughout adulthood. 
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Figure 2.1 shows the prevalence of several behavioural and biomedical risk factors in the 
Indigenous population at different ages, according to AATSIHS data.  
 
Notes  
1. Data for smoking and high cholesterol were self-reported. Data for overweight/obese and high blood pressure were based on physical 
measurements.  
2. Data for this figure are shown in Appendix Table C2.1. 
Source: ABS 2013a. 
Figure 2.1: Prevalence of selected behavioural and biomedical risk factors among Indigenous 
Australians aged 15 and over, by age, 2012–13 
Unresolved risk factors throughout the life cycle increase the risk of Indigenous Australians 
developing CHD. The problem is further exacerbated if there is limited change in risky 
health behaviours after clinical diagnosis (AIHW 2011a).  
Trends in CHD risk factors  
Trends in CHD risk factors among the Indigenous population can be tracked using the 2001 
National Health Survey (Indigenous), NATSIHS data from 2004–05 and AATSIHS data from 
2012–13. Some additional data are available from the 2008 National Aboriginal and Torres 
Strait Islander Social Survey. Smoking, alcohol consumption exceeding lifetime risk 
guidelines, fruit and vegetable consumption, and diabetes are among the risk factors that can 
be monitored over time using data from two or more of these surveys. However, due to 
changes in the way questions were asked or variables were measured in subsequent surveys, 
not all CHD risk factors can be compared across each of the 4 time points. 
While rates of tobacco smoking have declined over time, the prevalence of other risk factors 
has increased or not changed. Figure 2.2 shows that the proportion of Indigenous people 
aged 18 and over who were current daily smokers fell significantly from 51% in 2001 to 44% 
in 2012–13 (ABS 2013a). This decline is encouraging, as research has shown that smoking 
cessation reduces the risk of experiencing a heart attack by 36%, and is potentially the most 
effective preventive measure for CHD (Godtfredsen & Prescott 2011). 
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Notes 
1. Data for 2008 are from the ABS National Aboriginal and Torres Strait Islander Social Survey. 
2. Data for this figure are shown in Appendix Table C2.2. 
Source: ABS 2013a. 
Figure 2.2: Prevalence of Indigenous current daily smokers aged 18 and over, 2001 to 2012–13 
(selected years) 
In contrast, the proportion who reported having diabetes or high sugar levels rose from 6% 
in 2001 to 8% in 2012–13, and the proportion in non-remote areas who consumed inadequate 
amounts of vegetables also rose from 92% in 2004–05 to 95% in 2012–13 (ABS 2013a). The 
ABS found that these increases were statistically significant. 
There was little change in the proportion of Indigenous Australians who consumed 
inadequate amounts of fruit between 2004–05 and 2012–13 (59% in both surveys), and in the 
proportion who exceeded the 2009 National Health and Medical Research Council 
(NHMRC) alcohol consumption guidelines for lifetime risk between 2001 and 2012–13 (19% 
and 20% respectively) (ABS 2013a). 
2.2 Prevalence 
While analysis specific to coronary heart disease was not available at the time of publication, 
preliminary data from the 2012–13 AATSIHS provide an indication of the proportion of 
Indigenous Australians who reported that they had a circulatory disease. In 2012–13, about 
4% of Indigenous adults surveyed reported that they had a circulatory disease such as 
coronary heart disease, stroke or other vascular disease (ABS 2013a). After adjusting for age 
differences in the populations, Indigenous Australians were 1.6 times as likely to report 
having one of these conditions as were non-Indigenous Australians.  
Another indicator of CHD prevalence is the rate of heart attacks. In 2011, after adjusting for 
differences in age structure, heart attack rates among Indigenous adults were twice as high 
as among other Australians (1,077 and 421 per 100,000 population, respectively) (AIHW 
2014a forthcoming). 
In the 2004–05 NATSIHS, 1.2% of Indigenous adults reported having CHD (AIHW 2008). 
Nearly two-thirds reported having angina while the remaining one-third had experienced a 
heart attack. The prevalence of CHD was associated with age, rising from 5% among those 
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aged 45–64 to 11% among those 65 and over (AIHW 2008). The self-reported prevalence of 
CHD was 2 to 3 times higher for Indigenous than for non-Indigenous adults across all age 
groups, except for those aged 65 and over. The gap was particularly large in middle-aged 
people, pointing to an earlier onset of CHD in the Indigenous population (AIHW 2008). After 
adjusting for differences in age structure, CHD was 1.7 times more common for Indigenous 
males and 2.7 times more common for Indigenous females than for their non-Indigenous 
counterparts. 
2.3 Hospitalisations 
CHD hospitalisations are commonly for suspected angina or for a heart attack. Between July 
2010 and June 2012, nearly 8,500 hospitalisations with a primary diagnosis of CHD were 
recorded for Indigenous people, which equated to 8 hospitalisations per 1,000 population. 
After adjusting for differences in age-structure, Indigenous Australians were hospitalised for 
CHD at 2.4 times the rate of non-Indigenous Australians. 
Hospitalisations for CHD occurred at a relatively young age in the Indigenous population, 
with 10 hospitalisations per 1,000 population among those aged 35–44 compared with 2 per 
1,000 population among the non-Indigenous population (Figure 2.3). For Indigenous people, 
the hospitalisation rate for CHD more than doubled between the ages of 35–44 and 45–54, 
and continued to rise with increasing age.  
At all ages, Indigenous CHD hospitalisation rates were considerably higher than for 
non-Indigenous Australians. In the 35–44 and 45–54 age groups, Indigenous CHD 
hospitalisation rates were between 4 and 7 times higher than non-Indigenous CHD 
hospitalisation rates. In absolute terms, the greatest difference in rates was observed in the 
55–64 age group (a rate difference of 23 hospitalisations per 1,000 population). For those aged 
65 and over, Indigenous CHD hospitalisation rates were 1.4 times higher than for 
non-Indigenous Australians. 
 
Note: Data for this figure are shown in Appendix Table C2.3. 
Source: AIHW National Hospital Morbidity Database. 
Figure 2.3: Age-specific hospitalisation rates for a principal diagnosis of coronary heart disease, by 
Indigenous status, July 2010 to June 2012 (hospitalisations per 1,000 population) 
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Indigenous males were hospitalised for CHD at 1.5 times the rate of Indigenous females 
between July 2010 and June 2012. Hospitalisation rates for CHD were also higher for males 
than females in the non-Indigenous population (a rate ratio of 2.3).  
There was a small increase between 2004–05 and 2011–12 in the age-standardised CHD 
hospitalisation rates for Indigenous males (from 16.7 to 18.0 hospitalisations per 1,000 
population) and little change for Indigenous females (11.9 to 11.8 per 1,000) (Figure 2.4). 
However, there was a decrease for both non-Indigenous males (from 10.3 to 8.4 per 1,000) 
and non-Indigenous females (4.7 to 3.6 per 1,000). 
Between 2004–05 and 2011–12, overall age-standardised CHD hospitalisation rates fell by 
22% for the non-Indigenous population, and increased by 1.8% for the Indigenous 
population. As a result, the difference in CHD hospitalisation rates for Indigenous and 
non-Indigenous Australians widened, from 6.8 per 1,000 population in 2004–05 to 8.8 in 
2011–12. 
 
Notes 
1.       Rates have been directly age-standardised to the 2001 Australian Estimated Resident Population. 
2.       Data for this figure are shown in Appendix Table C2.4. 
Source: AIHW National Hospital Morbidity Database. 
Figure 2.4: Age-standardised CHD hospitalisation rates, by Indigenous status and sex, NSW, Vic, 
Qld, WA, SA and NT combined, 2004–05 to 2011–12 (hospitalisations per 1,000 population) 
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Coronary procedures while hospitalised 
Several coronary procedures can be performed on hospitalised CHD patients to improve 
blood flow to the heart (see Box 2.2 for descriptions of these procedures).  
Box 2.2: Coronary procedures 
Coronary angiography involves taking an X-ray of the heart using an injected contrast dye. 
As the dye moves through the coronary arteries, an X-ray is taken to see if the arteries are 
narrowed or blocked. 
Percutaneous coronary intervention (PCI) is a procedure that increases blood flow to the 
heart by inserting a thin tube into the coronary arteries. A small balloon attached to the end 
of the tube is inflated inside one or more narrowed coronary arteries. Stents (small mesh 
tubes) may be inserted to support the inner wall of the affected artery and to keep it open. 
PCI is also known as coronary angioplasty. 
Coronary artery bypass graft (CABG) is a surgical procedure that grafts a blood vessel 
from the leg or forearm to bypass a coronary artery blockage. 
While in hospital for CHD, Indigenous Australians were less likely than non-Indigenous 
Australians to undergo a coronary procedure (Figure 2.5). Between July 2010 and June 2012, 
less than one third (32%) of Indigenous hospitalisations for CHD involved coronary 
angiography compared with one half (52%) of non-Indigenous hospitalisations after 
adjusting for age. Similarly, about half as many Indigenous as non-Indigenous CHD 
hospitalisations involved PCI (13% compared with 24%). However, rates of coronary artery 
bypass grafts were similar between CHD hospitalisations of Indigenous and non-Indigenous 
Australians (a rate ratio of 0.93).  
 
Notes 
1.      Indigenous rates were age-standardised using the age-specific rates of non-Indigenous Australians. 
2.      Data for this figure are shown in Appendix Table C2.5. 
Source: AIHW National Hospital Morbidity Database. 
Figure 2.5: Use of coronary procedures during hospitalisations for CHD, by Indigenous status, July 
2010 to June 2012 
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Reasons for lower rates of coronary procedures during Indigenous hospitalisations for CHD 
may include: lower rates of private health insurance coverage, lower level of access to 
private hospitals (where many of these procedures are performed), later presentation to 
hospital (which can affect treatment options), clinical judgements regarding patient 
compliance post-procedure, communication issues, and patient knowledge and attitudes 
(AHMAC 2012). 
2.4 Mortality 
CHD was responsible for 1,598 Aboriginal and Torres Strait Islander deaths between 2007 
and 2011, representing 14% of all deaths for this population group. This was similar to the 
proportion of deaths represented by CHD in the non-Indigenous population (16%). 
However, there are clear differences in the age profile of CHD deaths in the 2 population 
groups. Mortality from CHD is high in the Aboriginal and Torres Strait Islander population 
from a relatively young age. A large proportion (81%) of Indigenous CHD deaths in  
2007–2011 occurred among those aged under 75. This is in contrast to the non-Indigenous 
population, where only 24% of CHD deaths occurred under the age of 75. Three-quarters of 
Indigenous CHD deaths were among people aged 35–74 (see Figure 2.6). 
 
Notes 
1. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
2. Data for this figure are shown in Appendix Table C2.6. 
Source: AIHW National Mortality Database. 
Figure 2.6: Indigenous and non-Indigenous deaths from CHD, by age, NSW, Qld, WA, SA and NT 
combined, 2007–2011  
Indigenous males were more likely to die from CHD as a primary cause than were 
Indigenous females, which is the same pattern seen in non-Indigenous Australians (Table 
2.3).  
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Table 2.3: Deaths from coronary heart disease, by Indigenous status and sex, NSW, Qld, WA, SA 
and NT combined, 2007–2011 
 Males  Females  Persons 
% of all 
deaths  Number Rate(a)  Number Rate(a)  Number Rate(a) 
Indigenous 1,014 226.2  584 128.1  1,598 172.2 14% 
Non-Indigenous 41,972 114.4  36,266 76.2  78,238 94.1 16% 
 (a) Per 100,000 population. Rates have been directly age standardised to the 2001 Australian Estimated Resident Population. 
Note: Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
Source: AIHW National Mortality Database. 
Similar to the non-Indigenous population, Indigenous males were more likely to die from 
CHD than Indigenous females across all ages (see Figure 2.7). In 2007–2011, the 
age-standardised death rate for Indigenous males was twice that for Indigenous females  
(226 compared with 128 per 100,000), whereas in the non-Indigenous population, the male 
death rate was 1.5 times as high as the female death rate. 
  
Notes 
1. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
2. Data for this figure are shown in Appendix Table C2.7. 
Source: AIHW National Mortality Database. 
Figure 2.7: Age-specific CHD death rates, by Indigenous status and sex, NSW, QLD, WA, SA and 
NT combined, 2007–2011 (deaths per 100,000 population) 
There was a statistically significant decline in CHD mortality over time in the Indigenous 
population, for both males and females. Between 2001 and 2011, the age-standardised CHD 
death rate fell by 36% in New South Wales, Queensland, Western Australia, South Australia 
and the Northern Territory combined (Figure 2.8). Non-Indigenous CHD mortality also fell 
significantly, by 35%, over this period. The gap in CHD mortality between the 2 population 
groups fell from 89 deaths per 100,000 population in 2001 to 54 deaths per 100,000 in 2011.  
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Notes 
1. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
2. Rates have been directly age-standardised to the 2001 Australian Estimated Resident Population. 
3. Data for this figure are shown in Appendix Table C2.8. 
Source: AIHW National Mortality Database.  
Figure 2.8: Age-standardised CHD death rates, by Indigenous status and sex, NSW, QLD, WA, SA 
and NT combined, 2001 to 2011 (deaths per 100,000 population) 
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3 Chronic obstructive pulmonary disease 
Chronic obstructive pulmonary disease is a serious long-term lung condition that is 
progressive and not fully reversible. It is characterised by shortness of breath (airflow 
limitation) with fits of coughing, and it mainly affects older people. Breathlessness from 
COPD progresses over time until it becomes severe upon minimal exertion (Box 3.1). The 
slow development of COPD may mean that its presence is not detected until there is severe 
damage to the lungs. The damaged lung tissue is unable to repair itself, and there is no cure 
for COPD. Medication can improve the symptoms and slow progression of the disease. 
Other forms of treatment, such as pulmonary rehabilitation and oxygen therapy, may also be 
effective but there is currently no national data on the effectiveness of these interventions 
(AIHW: Marks et al. 2013). 
Box 3.1: Clinical presentation of COPD 
COPD encompasses several long-term, progressive lung conditions. The 2 most common 
conditions are chronic bronchitis and emphysema. In chronic bronchitis, the lungs 
constantly overproduce mucus that can lead to a chronic, productive cough. Emphysema 
occurs when the air passages (bronchi and bronchioles) and air sacs (alveoli) of the lung are 
damaged, causing breathlessness. Each form of COPD can present on its own, or together in 
the same person.  
The development and progression of COPD is characterised by an ongoing reduction in 
lung capacity and increasing shortness of breath, which can become so severe that 
assistance is required with everyday tasks. Based on the reduction in lung capacity 
(measured using a breathing test called spirometry) and other signs and symptoms, the 
progression of COPD can be divided into 4 stages: mild, moderate, severe and restrictive. 
Other signs and symptoms include cough, shortness of breath, increased sputum 
production, wheezing and chest tightness.  
COPD is a large source of morbidity, disability and mortality in Australia and internationally 
(Devereux 2006). The financial costs of COPD are also high. In 2008–09, estimated 
expenditure for COPD in Australia (based primarily on hospital admitted patient services, 
out-of-hospital medical expenses and prescription pharmaceuticals) was $929 million, which 
accounted for 1.3% of total direct expenditure on all diseases (AIHW 2013c). The major costs 
were hospital costs for admitted patients (58%) and prescription medicines (23%). 
According to the Global Burden of Disease Study 2010, COPD ranked third for burden of 
disease in Australasia after CHD and low back pain (AIHW 2013f). COPD is a large 
contributor to the burden of disease in the Indigenous population as well. In 2003, COPD 
was responsible for 4% of the total burden of disease among Aboriginal and Torres Strait 
Islander peoples, and chronic respiratory diseases overall were the third leading contributor 
to burden of disease in the Indigenous population (Vos et al. 2007).  
3.1 Risk factors 
Many factors can contribute to the development and progression of COPD. The major risk 
factor for COPD is tobacco smoking; however, there are a range of other risk factors, such as 
environmental and biological factors (Table 3.1).  
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Table 3.1: Known risk factors for COPD incidence, severity and mortality 
Non-modifiable Modifiable May or may not be modifiable 
age tobacco smoking low socioeconomic status 
genetic factors (e.g. alpha-1 antitrypsin deficiency)  occupational dust, vapours, and fumes 
  indoor air pollutants (from biomass fuels 
such as straw, coal) 
  outdoor air pollutants 
  recurrent childhood infections 
Source: Mannino & Buist 2007. 
Long-term tobacco smoking and environmental exposure to pollutants can trigger chronic 
inflammation of the airways through noxious chemicals. Exposure to various bacterial and 
viral infections in childhood and polluted air are other common risk factors. Childhood 
lower respiratory tract infections can impair lung growth and make these children more 
vulnerable to developing COPD in later life if exposed to smoking or other pollutants  
(Sethi 2000). Rare genetic conditions such as alpha-1 antitrypsin deficiency can cause COPD 
in people who have never smoked or been exposed to irritants. While rates of COPD are 
higher in men than in women, this is likely to be related to patterns in smoking and 
occupational exposure (Mannino & Buist 2007). 
Data on COPD risk factors in the Indigenous population, other than tobacco smoking, are 
limited. Several reports have described the high prevalence of bacterial and viral infections 
leading to respiratory illness in Indigenous children (Maguire 2004). Adult respiratory 
infections have also been reported to contribute to acute exacerbations of COPD in the 
Indigenous population (Thomas et al. 2006).  
Tobacco smoking 
Tobacco smoking, as well as exposure to environmental tobacco smoke, is relatively common 
in the Indigenous population. According to the 2012–13 AATSIHS and as noted in Section 
2.1, 44% of Indigenous Australians aged 18 and over smoked tobacco daily. Another 2% 
were intermittent smokers, 22% were ex-smokers and 32% had never smoked tobacco  
(ABS 2013a). After adjusting for age, Indigenous adults were 2.6 times as likely to report that 
they were current daily smokers as were non-Indigenous adults (Table 3.2). In both 
populations, men aged 18 and over were more likely than women aged 18 and over to be 
current or ex-smokers. However, the difference between men and women was greater 
among the non-Indigenous population. 
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Table 3.2: Smoker status of Australians adults, by Indigenous status and sex, 2012–13 
 Indigenous (%)  Non-Indigenous(a) (%) 
Rate ratio(b) 
(persons)  Males Females Persons  Males Females Persons 
Current daily smoker 45.4 42.2 43.8  17.8 13.6 15.7 2.6 
Current intermittent smoker(c) 2.1 2.1 2.1  2.0 1.6 1.8 1.0 
Ex-smoker 22.0 22.8 22.4  35.4 26.9 31.1 0.9 
Never smoked 30.6 33.0 31.8  44.8 57.8 51.4 0.6 
Total(d) 100.0 100.0 100.0  100.0 100.0 100.0 . . 
. .  not applicable 
(a)  Data for non-Indigenous people are for 2011–12, from the Australian Health Survey 2011–13. 
(b)  Rate ratio is calculated by dividing the age-standardised Indigenous rate by the age-standardised non-Indigenous rate. 
(c) Includes smokers who smoked weekly (at least once a week, but not daily) and those who smoked less than weekly. 
(d) Totals may not sum to 100 due to rounding. 
Source: ABS 2013a. 
Cessation of tobacco smoking is the most effective way to improve COPD outcomes 
(Srivastava et al. 2006). However, only a small proportion of patients with respiratory 
illnesses give up smoking (Manning & Kin 2006). In 2004–05, regular tobacco smoking was 
reported at the same levels among Australians with or without self-reported long-term 
respiratory illnesses (asthma, COPD and other long-term respiratory problems) in both the 
Indigenous and non-Indigenous populations (Table 3.3) (AIHW 2013a).  
Table 3.3: Long-term respiratory problems in Australian adults, by Indigenous status and smoker 
status, 2004–05 (age-standardised rates) 
Respiratory problems 
Indigenous (%) 
 
Non-Indigenous (%) 
Current 
smoker 
Ex- 
smoker 
Never 
smoked Total 
Current 
smoker 
Ex- 
smoker 
Never 
smoked Total 
Present 47.5 24.3 28.1 100.0  22.6 31.0 46.4 100.0 
Absent 48.7 23.2 28.2 100.0  23.3 29.3 47.3 100.0 
Notes  
1. Rates have been directly age standardised to the 2001 Australian Estimated Resident Population. 
2. Totals may not sum to 100 due to rounding. 
Source: AIHW analysis of ABS 2004–05 National Aboriginal and Torres Strait Islander Health Survey. 
Trends in tobacco smoking in the Indigenous population 
High exposure to tobacco smoke may start early in life for some Indigenous Australians, 
with about 1 in 5 children (21%) exposed to passive smoking inside the house in 2008, 
compared with 7% of non-Indigenous children (ABS 2012). The initiation to tobacco smoking 
can also begin early with 18% of Indigenous adolescents aged 15–17 smoking daily in  
2012–13, compared with 4% of non-Indigenous adolescents (ABS 2013a).  
The proportion of Indigenous daily smokers declined with increasing age. More than half 
Indigenous Australians aged 25–34 (52%) smoked daily in 2012–13, compared with 26% of 
those aged 55 and over. The prevalence of smoking in the Indigenous population is almost 
equal in both sexes, but slightly lower among women across all age groups (ABS 2013a).  
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Tobacco smoking is on the decline in the Indigenous population overall. Between 2002 and 
2012–13, the proportion of Indigenous males aged 15 and over that smoked daily fell from 
51% to 43%. The decrease in females was from 47% to 39% over the same period (ABS 2013a). 
The proportion of non-Indigenous daily smokers also fell from 22% in 2001 to 16% in  
2011–12. 
Children’s exposure to environmental tobacco smoke in the home is also on the decline. 
Almost 3 in 10 children aged 0–14 (29%) lived in a household where members usually 
smoked indoors in 2004–05; the figure was 21% in 2008 (ABS 2012).  
3.2 Prevalence 
The prevalence of COPD is difficult to determine as some cases are not diagnosed until late 
in the disease’s progress, and the disease often goes undiagnosed in its mild form. Further, 
self–reported prevalence estimates of COPD are considered to be lower than the actual 
prevalence by almost 50% in the absence of diagnosis with a lung function test such as 
spirometry (Halbert et al. 2006).  
An assessment of various COPD prevalence studies suggests that about 1 in 5 Indigenous 
Australians may have moderate to severe COPD (TSANZ 2010). However, in the 2012–13 
AATSIHS, only 4% of Indigenous people reported having COPD. This substantially lower 
proportion may be due to the condition not yet being diagnosed by a doctor, and therefore 
not reported by survey respondents. The prevalence of self-reported COPD was similar in 
females (4.3%) and males (4.0%). After adjusting for differences in the age structure of the 
populations, Indigenous Australians were 2.5 times as likely to report having COPD as were 
non-Indigenous Australians (Figure 3.1). Indigenous Australians living in remote areas have 
been reported to have a higher prevalence of COPD than Indigenous people living in 
metropolitan or regional areas (TSANZ 2010). 
 
Notes 
1. Rates have been directly age standardised to the 2001 Australian Estimated Resident Population. 
2.  Data for non-Indigenous people are for 2011–12, from the Australian Health Survey 2011–13. 
3. Data for this figure are shown in Appendix Table C3.1. 
Source: ABS 2013a.  
Figure 3.1: Age-standardised rates of Australians reporting COPD, by Indigenous status and sex, 
2012–13 (per cent) 
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3.3 Hospitalisations 
People with COPD may require hospitalisation to treat acute exacerbations of the disease. 
Between July 2010 and June 2012, there were 6,231 hospitalisations of Indigenous people for 
which the principal diagnosis was COPD. After adjusting for age, Indigenous 
hospitalisations for COPD were 5 times as high as for non-Indigenous Australians  
(Table 3.4). There were 6 times as many COPD hospitalisations for Indigenous females as for 
non-Indigenous females.  
Table 3.4: Hospitalisations for a principal diagnosis of COPD, by Indigenous status and sex, July 
2010 to June 2012  
 
Indigenous 
 
Non-Indigenous 
 
Total(a)  
 Rate 
difference(d) Sex  Number Rate(b)   Number Rate(b)   Number Rate(b) 
 Rate 
ratio(c) 
Males 2,612 12.7   64,929 2.9   68,077 3.0   4.4 9.8 
Females 3,619 12.9   55,476 2.1   59,769 2.3   6.2 10.8 
Persons 6,231 12.7   120,405 2.4   128,115 2.6   5.2 10.3 
(a)  Includes hospitalisations for which Indigenous status was not stated.  
(b)  Per 1,000 population. Rates have been directly age-standardised to the 2001 Australian Estimated Resident Population. 
(c)  Rate ratio is calculated by dividing the Indigenous rate by the non-Indigenous rate. 
(d)  Rate difference is calculated by subtracting the non-Indigenous rate from the Indigenous rate. 
Source: AIHW National Hospital Morbidity Database. 
The high rate-ratios seen in Table 3.4 may reflect the greater prevalence or severity of COPD 
in the Indigenous population requiring hospitalisation. Indigenous Australians are 
hospitalised for COPD at higher rates than non-Indigenous Australians across all age groups 
(Figure 3.2). Between July 2010 and June 2012, the Indigenous COPD hospitalisation rate 
exceeded 12 per 1,000 population among those aged 45–54, and was almost 28 per 1,000 in 
the 55–64 age group. The respective non-Indigenous rates were 1 and 4 per 1,000. 
 
Note: Data for this figure are shown in Appendix Table C3.2. 
Source: AIHW National Hospital Morbidity Database.  
Figure 3.2: Age-specific hospitalisation rates for a principal diagnosis of COPD, by Indigenous 
status, July 2010 to June 2012 (hospitalisations per 1,000 population) 
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Hospitalisations for COPD have increased over time in the Indigenous population. The 
number of hospitalisations increased from 2,103 in 2004–05 to 3,258 in 2011–12. There was 
also an increase in the COPD hospitalisation rate from 2004–05 to 2011–12 for Indigenous 
females (Figure 3.3). That rate increased by more than 25% in the 7-year period. The COPD 
hospitalisation rate fluctuated for Indigenous males over this period.  
 
Notes 
1.  Rates have been directly age-standardised to the 2001 Australian Estimated Resident Population.  
2.  Data for this figure are shown in Appendix Table C3.3. 
Source: AIHW National Hospital Morbidity Database. 
Figure 3.3: Age-standardised hospitalisation rates for COPD, by Indigenous status and sex, NSW, 
Vic, Qld, WA, SA and NT combined, 2004–05 to 2011–12 (hospitalisations per 1,000 population) 
Non-Indigenous hospitalisation rates for COPD remained relatively stable over the period 
2004–05 to 2011–12, however there was a fall in the rates for males from 3.3 per 1,000 
population in 2004–05 to 2.9 per 1,000 in 2011–12. The difference between Indigenous and 
non-Indigenous COPD hospitalisations significantly increased by 17% between 2004–05 and 
2010–11. 
3.4 Mortality 
In 2007–2011, COPD was responsible for 442 Indigenous deaths in New South Wales, 
Queensland, Western Australia, South Australia and the Northern Territory combined. 
Deaths from COPD occurred at an earlier age in the Indigenous population than in the 
non-Indigenous population and became more common with increasing age (Figure 3.4). 
Similar to the pattern seen in CHD, deaths from COPD among Indigenous people were more 
likely to occur before the age of 75 than deaths among non-Indigenous people (69% 
compared with 29%).  
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Notes 
1. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
2. Data for this figure are shown in Appendix Table C3.4. 
Source: AIHW National Mortality Database. 
Figure 3.4: Indigenous and non-Indigenous deaths from COPD, by age, NSW, Qld, WA, SA and NT 
combined, 2007–2011 
The age-standardised Indigenous death rate of 61 per 100,000 population in 2007–2011 was 
almost 3 times as high as the rate for the non-Indigenous population (22 per 100,000). COPD 
death rates in 2007–2011 were higher in Indigenous males than females across all age groups, 
which was a pattern also seen in the non-Indigenous population (Figure 3.5). 
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Notes 
1. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
2. Data for this figure are shown in Appendix Table C3.5. 
Source: AIHW National Mortality Database. 
Figure 3.5: Age-specific deaths rates from COPD, by Indigenous status and sex, NSW, Qld, WA, SA 
and NT combined, 2007–2011 (deaths per 100,000 population) 
While there was a statistically significant decline in the COPD death rate for non-Indigenous 
males over the period 2001 to 2011, there was no statistically significant trend for Indigenous 
males and females, as well as non-Indigenous females (Figure 3.6).  
No differences in tobacco smoking patterns and trends based on gender have been seen in 
the Indigenous and non-Indigenous population to explain the significant death rate decrease 
in non-Indigenous men but not in the other groups. As noted earlier, rates of smoking have 
fallen for both Indigenous and non-Indigenous men and women. There is some evidence to 
suggest that females have heightened susceptibility to cigarette smoke or other forms of air 
pollution compared with males (Sørheim et al. 2010), and this may explain some of the 
difference in COPD mortality trends between men and women. Contrasting sex-specific 
trends in COPD mortality have been noted in populations around the world (López-Campos 
et al. 2014; O’Farrell et al. 2011), and have been attributed to converging patterns in tobacco 
smoking, which until recently were on the decline for males in Australia, but rising in 
females (Harris 2013).  
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Notes 
1. Rates have been directly age-standardised to the 2001 Australian Estimated Resident Population. 
2. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
3. Data for this figure are shown in Appendix Table C3.6. 
Source: AIHW National Mortality Database.  
Figure 3.6: Age-standardised COPD death rates, by Indigenous status and sex, NSW, QLD, WA, SA 
and NT combined, 2001 to 2011 (deaths per 100,000 population) 
Declines in COPD mortality in the Indigenous population have been reported previously 
from the Northern Territory by Thomas and others (2006). In the absence of any decrease in 
tobacco smoking in the preceding decade in the Northern Territory, they attributed these 
declines to improved foetal growth in the womb, fewer childhood infections, better nutrition, 
less overcrowding and advances in the management of acute exacerbations of COPD. 
The contribution of COPD to overall mortality is said to be underestimated (Manning & Kin 
2006). In the United Kingdom, about 60% of deaths in people with COPD listed COPD as the 
primary cause of death but, in Finland, this figure was 37%. In Australia, between 1997 and 
2007, COPD was listed as the ‘underlying’ or primary cause for 42% of deaths involving 
COPD; thus, for over half of these deaths (58%), COPD was listed as an ‘associated’ cause 
(AIHW 2012a). 
3.5 COPD, lung cancer and tobacco smoking 
There is evidence of a relationship between COPD and lung cancer, since a dominant cause 
of both diseases is tobacco smoking, and the impaired lung function of people with COPD 
increases their lung cancer risk (Harris 2013). The risk is much higher in COPD patients with 
severe disease (Purdue et al. 2007). 
A close parallel was noted between cigarette use and mortality from both COPD and lung 
cancer with COPD deaths occurring about 15 to 20 years earlier than lung cancer. Declines in 
smoking rates are seen to affect COPD death rates earlier than lung cancer rates because 
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COPD generally develops earlier than lung cancer in the life of a continuous smoker, and the 
beneficial effects of smoking cessation are more immediate for COPD than for lung cancer 
(AIHW 2010).  
Death rates for both COPD and lung cancer are in decline in Australia, with deaths from 
lung cancer greater than those from COPD since the 1990s (AIHW 2010). In contrast, for the 
Indigenous population, there has been a significant increase in lung cancer death rates but 
there has not been a significant change in rates for COPD. In 2011, deaths rates from lung 
cancer were at similar levels to death rates from COPD among Indigenous people (Figure 
3.7).  
 
Notes 
1. Rates have been directly age-standardised to the 2001 Australian Estimated Resident Population. 
2. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
3.       Data for this figure are shown in Appendix Table C3.7. 
Source: AIHW National Mortality Database. 
Figure 3.7: COPD and lung cancer mortality, by Indigenous status, 2001 to 2011 (deaths per 100,000 
population) 
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4 Using indicators to monitor CHD and 
COPD management 
The surveillance and monitoring of chronic diseases involves more than just looking at 
trends in disease occurrence, hospitalisations and mortality. It also needs to take into 
consideration: relevant risk factors (including behavioural, biomedical, occupational, 
environmental, psychosocial and socioeconomic); comorbidities; medical interventions; 
disabilities; and the mix of underlying causes of death. A life course approach to the 
development and progression of chronic diseases is integral to any surveillance and 
monitoring strategy.  
A considered approach to chronic disease monitoring is to develop indicators of progress 
across various aspects of disease processes and outcomes, and to report against them 
regularly. Australian governments are making a concerted effort to monitor the health of 
Indigenous Australians using a set of indicators guided by the Aboriginal and Torres Strait 
Islander Health Performance Framework (HPF). Many of these indicators cover various 
important aspects of chronic diseases such as risk factors, prevalence, interventions, 
hospitalisations and mortality (AHMAC 2012). Detailed information on these indicators is 
being generated by the AIHW on a regular basis (AIHW 2011a, 2013a).  
For example, analysis of Medicare data conducted for HPF reporting has shown that the 
rates of Medicare Benefits Schedule (MBS) health checks for Indigenous people have 
increased significantly between 2006–07 and 2011–12 (AIHW forthcoming). These health 
checks aim to improve the early detection and treatment of health conditions. Over this 
period, the rate of MBS health checks for Indigenous Australians: 
• aged 0–14 increased from 33 per 1,000 to 154 per 1,000 population 
• aged 15–54 increased from 45 to 158 per 1,000 population 
• aged 55 and over increased from 85 to 256 per 1,000 population (Figure 4.1). 
 
Note: Data for this figure are shown in Appendix Table C4.1. 
Source: AIHW forthcoming. 
Figure 4.1: MBS health checks for Indigenous Australians, by age, 2006–07 to 2011–12 (number per 
1,000 population) 
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Ideally, an indicator framework that is specifically concerned with assessing the progression 
of CHD and COPD in the Indigenous population will be developed to assist in the 
understanding of disease progression and management in Indigenous people. However, 
until then, indicators in other frameworks can provide some insight into these areas. For 
example, government programs targeting Indigenous chronic diseases have been evaluated 
and the results relating to CHD and COPD are outlined below. 
4.1 Healthy for Life  
Healthy for Life (HfL) is an Australian Government-funded program aimed at improving 
Indigenous health. One of its objectives is to improve the prevention, early detection and 
management of chronic disease. The program collects and reports on service activities and 
health outcome data. It is available to: primary health-care providers in Aboriginal 
Community Controlled Health Services (ACCHS), state and territory health services, and 
Divisions of General Practice (which were superseded by Medicare Locals). ACCHSs 
comprise about 65% of the services participating in the program. 
The AIHW published a national report on the HfL program in 2013 (AIHW 2013b). Findings 
in regard to CHD were: 
• The number of Indigenous clients with CHD with a General Practitioner Management 
Plan (GPMP) almost doubled, from 405 in 2007–08 to 750 in 2010–11 (Figure 4.2). The 
proportion of Indigenous clients with CHD with a General Practitioner Management 
Plan increased from 23% to 34% in this period. 
• The number of Indigenous clients with CHD who had a Team Care Arrangement (TCA) 
(allowing GPs to coordinate patient care with other health-care providers) increased by 
over 100% from 215 in 2007–08 to 453 in 2010–11 (Figure 4.2). Over this period the 
proportion of Indigenous clients with CHD who had a Team Care Arrangement 
increased from 13% to 22%. 
 
Note: Data for this figure are shown in Appendix Table C4.2. 
Source: AIHW 2013b. 
Figure 4.2: Indigenous clients with CHD with a General Practitioner Management Plan and a Team 
Care Arrangement, 2007–08 to 2010–11 
In addition, the number of Indigenous clients with CHD who had a blood pressure test in the 
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and 63% of these clients, respectively (Figure 4.3). The proportion whose blood pressure 
result was favourable (less than 140/90mmHg) ranged from 61% in July–December 2007 and 
January–30 June 2010 to 66% in July–December 2010. Note that comparisons cannot be made 
with results recorded after 2010 because the data specified for this indicator changed in 
January–June 2011 to blood pressure less than or equal to 130/80 mmHg. 
 
Notes 
1. Blood pressure results data are not available for 2010–11 because the data specified for this indicator changed in January–June 2011. 
2. Data for this figure are shown in Appendix Table C4.3. 
Source: AIHW 2013b. 
Figure 4.3: Indigenous clients with CHD who had a blood pressure test in the last 6 months and 
whose blood pressure was less than 140/90 mmHg, 2007–08 to 2010–11 
4.2 National Key Performance Indicators for 
Indigenous-specific primary health-care 
services 
From June 2012, reporting on the Healthy for Life program was replaced with the 
Indigenous primary health-care national Key Performance Indicators (nKPI) data collection. 
As with the HfL program, the nKPIs focus on chronic disease prevention and management, 
and on maternal and child health.  
The purpose of the nKPIs is to improve the delivery of primary health-care services by 
supporting continuous quality improvement activity among service providers. The nKPIs 
also support policy and planning at the national and jurisdictional level by allowing 
monitoring of progress and highlighting areas for improvement. 
In 2012–13, data pertaining to 19 indicators were collected from 206 primary health-care 
organisations that receive funding from the Australian Government Department of Health to 
provide services primarily to Aboriginal and Torres Strait Islander people. A number of 
these indicators relate to chronic disease detection, prevention and management; however 
the indicators mainly relate to clients with Type II diabetes or cardiovascular diseases more 
broadly, and not to coronary heart disease specifically. Examples of such indicators are as 
follows: proportion of clients who had a cardiovascular risk assessment; proportion of 
regular clients with diabetes who had a General Practitioner Management Plan or Team Care 
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Arrangement; and proportion of clients with diabetes who had their blood pressure 
measured and recorded. From December 2014, the outcome of clients’ cardiovascular risk 
assessments will also be collected. 
The only indicator of the 19 nKPIs currently collected on COPD is the proportion of regular 
clients with COPD who were immunised against influenza. Regular clients are people who 
have an active medical record—that is, people who attended the primary health-care 
organisation at least 3 times in the last 2 years. Data at June 2013 indicate that, nationally, 
34% of Indigenous regular clients with COPD aged 15–49 were immunised against influenza 
(AIHW 2014c). 
4.3 Evaluation of the Indigenous Chronic Disease 
Package  
The AIHW undertook a review of the effectiveness, efficiency and appropriateness of the 
National Partnership Agreement (NPA) on Closing the Gap in Indigenous Health Outcomes, 
based on information from the first 3 years’ of its implementation (2009–10 to 2011–12). Part 
of the NPA included the Indigenous Chronic Disease Package (ICDP). The first and second 
years of the ICDP’s implementation were also evaluated by KPMG (KPMG 2013a, 2013b). 
Their evaluation of the first year was used as a baseline for monitoring progress in 
subsequent years. An evaluation of the Sentinel Sites, which were locations chosen for 
monitoring the ICDP implementation, was also undertaken by the Menzies School of Health 
Research over the period 2010 to 2013 (Bailie et al. 2013). Key findings of these evaluations 
are summarised below.  
Progress in reducing chronic disease risk factors 
Progress to reduce smoking rates among Indigenous people has been made. Implemented 
measures included: 
• a new workforce aimed at tackling Indigenous smoking, made up of a National 
Coordinator for Tackling Indigenous Smoking and a national network of 37 Regional 
Tobacco Coordinators and 59 Tobacco Action Workers (at 31 July 2012)  
• the ‘Break the Chain’ advertising campaign—Australia’s first national anti-smoking 
advertising campaign with a focus on Indigenous people—was launched in March 2011.  
In addition, there was also increased uptake of smoking-cessation medicines over 2010–11 by 
the Indigenous population (which was likely to also have been influenced by non-ICDP 
initiatives). 
Management of chronic disease and follow-up care 
At 31 July 2012, the following achievements were noted: 
• greater than expected uptake of the Practice Incentives Program (PIP) Indigenous Health 
Incentive in terms of expenditure and patient registration payments. More than 3,100 
general practices and around 150 Indigenous health services had signed on to the 
program, which supports general practices and Indigenous health services to improve 
the care they provide to Indigenous patients. However, incentive payments for practices 
to provide chronic disease management were less than expected—only 4% of registered 
practices triggered the Tier 1 payment, which requires the development and review of a 
GPMP or TCA (AIHW 2013e). 
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• greater than expected uptake of Closing the Gap Pharmaceutical Benefits Scheme (PBS) 
prescriptions in the 12 months to 31 May 2011. This program allows more Indigenous 
people living in remote areas to access more affordable—and in some instances free—
PBS medicines. At 30 June 2012, approximately 150,000 Indigenous people with, or at 
risk of, chronic disease had accessed the initiative, with 96% (5,127) of pharmacies 
participating and over 2.7 million prescriptions dispensed. 
• multidisciplinary health outreach teams provided 541 services nationally in regional and 
remote Indigenous communities in 2010–11, compared with 148 across New South 
Wales, Queensland and Western Australia in 2009–10. 
Workforce expansion and support 
At 31 July 2012, the following achievements were noted: 
• 95 new Indigenous Health Project Officers were introduced  
• Divisions of General Practice and Indigenous health services were funded to employ 128 
Aboriginal and Torres Strait Islander Outreach Workers  
• an additional 20 practice managers and 13 health professionals were funded to increase 
the capacity of Indigenous health services 
• 46 new general practitioner registrar training posts were created in Indigenous health 
services 
• 87 new Care Coordinators (who coordinate patients’ access to health services consistent 
with their General Practitioner Management Plans) were funded (KPMG 2013a, 2013b). 
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5 Conclusion 
Age-specific prevalence, hospitalisation and mortality data for CHD and COPD point to a 
pattern of chronic disease in the Indigenous population which is different from that 
experienced by the non-Indigenous population. Not only are these diseases prevalent at 
younger ages and at higher rates across all age groups in the Indigenous population 
(particularly in the middle aged), but their progression to advanced disease, related 
complications and death also appears to occur at younger ages. Reasons for these differences 
include a higher prevalence of risk factors, such as smoking, and poorer access to health 
services among the Indigenous population, which can delay the diagnosis and treatment of 
these conditions (Gracey & King 2009). 
Declines in Indigenous CHD mortality between 2001 and 2011 are highly encouraging, as is 
the fall in Indigenous smoking rates from 2001 to 2012–13. However, increases in other CHD 
risk factors in the Indigenous population, such as diabetes and poor diet, may affect this 
downward trend into the future.  
A combination of various factors could be contributing to the downward trend in CHD 
mortality including declining smoking rates, improved chronic disease treatment and 
management, and changes to individuals’ socioeconomic and environmental conditions. 
Further research is required to fully understand all of the factors and to separate and 
quantify these effects. 
Primary prevention can play a much larger role in improving the cardiovascular and 
pulmonary health of Indigenous Australians. Behavioural risk factors for CHD, including 
those contributing to overweight and obesity, need to be addressed, along with biomedical 
factors such as the high prevalence of diabetes. Smoking-cessation programs and early 
management of acute respiratory illnesses in Indigenous Australians are also important 
strategies for alleviating the burden of COPD on the Indigenous community.  
Progress towards reducing the burden of CHD and COPD in the Indigenous community can 
be monitored using indicators that track chronic disease risk factors and medical 
interventions more broadly. Monitoring of recent government programs has found that 
progress has been made in smoking cessation and blood pressure management, and in the 
uptake of GP Management Plans, Team Care Arrangements and Closing the Gap PBS 
prescriptions. The development of an indicator framework that is specific to assessing the 
progression of CHD and COPD among Indigenous people can further improve the 
understanding of these diseases’ progression and management in this population. 
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Appendix A: Data sources 
National Mortality Database 
Mortality data have been extracted from the AIHW’s National Mortality Database. Data are 
sourced from the Registrars of Births, Deaths and Marriages in each state and territory and 
from the National Coronial Information System, and compiled and coded by the ABS. The 
ABS codes the cause of death using the International Statistical Classification of Diseases and 
Related Health Problems and passes the data to the AIHW for inclusion in the National 
Mortality Database. Although the database includes multiple causes of death, only the 
underlying (or primary) cause is used in the analyses presented in this paper. 
Mortality data are presented for New South Wales, Queensland, Western Australia, South 
Australia and the Northern Territory combined as these jurisdictions are considered to have 
adequate levels of identification of Indigenous people in their death registration systems for 
analyses from 2001 onwards.  
In order to accommodate small numbers and year-to-year variability in some cause-of-death 
data for Indigenous Australians, most of the analyses were conducted on combined deaths 
for the 5-year period 2007 to 2011 rather than on 2011 data alone.  
Deaths registered in 2010 for individuals with a usual residence of Queensland have been 
adjusted to exclude deaths registered in 2010 that occurred prior to 2007. This is to minimise 
the impact of late registration of deaths due to recent changes in the timeliness of death 
registrations in Queensland. 
For more information about deaths in Australia and data quality, refer to ABS Deaths, 
Australia (ABS cat. no. 3302.0) and ABS Causes of death, Australia (ABS cat. no. 3303.0), which 
are available from <http://www.abs.gov.au.>. 
National Hospital Morbidity Database 
Hospitalisation data have been extracted from the AIHW’s National Hospital Morbidity 
Database, which is a compilation of episode-level records from admitted patient morbidity 
data collection systems in Australian hospitals in each state and territory. Information on the 
characteristics, diagnoses and care of admitted patients in public and private hospitals is 
provided annually to the AIHW by state and territory health departments. 
Hospitalisation data are presented for the 2-year period from July 2010 to June 2012. An 
aggregate of 2 years of data has been used because the number of hospitalisations for some 
conditions for Indigenous Australians is likely to be small for a single year. 
Statistics on admitted patients are compiled when an admitted patient (that is, a patient who 
undergoes a hospital’s formal admission process) completes an episode of admitted patient 
care and ‘separates’ from the hospital. This is because most of the data on the use of hospitals 
by admitted patients are based on information provided at the end of the patient’s episode of 
care, rather than at the beginning. The length of stay and the procedures carried out are then 
known and the diagnostic information is more accurate. The principal diagnosis is the 
diagnosis established, after study, to be chiefly responsible for occasioning the patient’s 
episode of admitted patient care. 
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Hospital records are for ‘separations’ and not individuals; since there can be multiple 
separations for the same individual, hospital separation rates do not usually reflect the 
number of people who were hospitalised. For example, it is not possible to identify whether 
1 patient was admitted 5 times or 5 patients were admitted once. 
In 2011–12, diagnoses and external causes of injury were recorded using the 7th edition of 
the International statistical classification of diseases and related health problems, 10th revision, 
Australian modification (ICD-10-AM) (NCCH 2010). It comprises classifications of diseases 
and external causes of injuries and poisoning based on the World Health Organization’s 
version of ICD-10. The ICD-10-AM classification is hierarchical, with 20 summary disease 
chapters that are divided into a large number of more specific disease groupings.  
Separations with a care type of ‘newborn’ (without qualified days) and records for ‘hospital 
boarders’ and ‘posthumous organ procurement’ have been excluded from the analyses 
presented in this paper. 
Hospital separation rates are presented for Indigenous and non-Indigenous Australians; 
separations for which Indigenous status was ‘not stated’ have been excluded from analyses 
presented in this paper. 
From 2010–11 onwards, Indigenous status information within hospital separations data from 
all jurisdictions were of sufficient quality for statistical reporting purposes (AIHW 2013d). 
An AIHW study found an estimated 88% of Indigenous patients were correctly identified in 
Australian public hospital admission records in 2011–12. Analyses in this paper therefore 
include data for all jurisdictions, except for time trend analyses, which present data for the 6 
jurisdictions that the AIHW has assessed as having adequate identification of Indigenous 
hospitalisations prior to 2010–11: New South Wales, Victoria, Queensland, Western 
Australia, South Australia and the Northern Territory (public hospitals only). Indigenous 
people in these 6 jurisdictions comprise approximately 96% of the Indigenous population of 
Australia. 
The complete data quality statement for the NHMD is available online at 
<www.aihw.gov.au/hospitals/>. 
Australian Aboriginal and Torres Strait Islander Health Survey  
Data on the prevalence of CHD, COPD and associated risk factors among Indigenous people 
were taken from the ABS 2012–13 AATSIHS. The AATSIHS surveyed about 9,300 Indigenous 
Australians living in remote and non-remote areas, including discrete communities. The first 
results from the AATSIHS were published in November 2013. Updated results based on a 
larger sample were released in June 2014. 
Compared with previous ABS health surveys about Indigenous people, two new 
components—the National Aboriginal and Torres Strait Islander Nutrition and Physical 
Activity Survey and the National Aboriginal and Torres Strait Islander Health Measures 
Survey—were added to the 2012–13 AATSIHS. These additions will provide biomedical 
results (such as cholesterol levels for Indigenous people aged 18 and over) which will be 
comparable with results for non-Indigenous people. The results from these two new 
components are expected to be released in late 2014. 
Data from the AATSIHS on the prevalence of chronic diseases are limited because they are 
self-reported. Self-reporting may depend on whether a survey respondent’s doctor has 
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diagnosed the condition, which means that some chronic diseases that have yet to be 
detected (for example, those in the early stages) may not be captured in the data. 
It is also difficult to monitor trends in some risk factors using the AATSIHS and earlier ABS 
Indigenous health surveys because the relevant questions changed over time. 
Healthy for Life 
The Healthy for Life (HfL) program was an Australian Government-funded program which 
aimed to improve the capacity and performance of primary health-care services to deliver 
high-quality maternal, children’s and chronic disease care to Aboriginal and Torres Strait 
Islander people. This was carried out through population-health approaches using 
best-practice and quality-improvement principles. 
Primary health-care services participating in the HfL program were required to submit 
de-identified, aggregate service data to the AIHW for 11 essential indicators on a 6- or 
12-monthly basis. These indicators covered maternal health, child health and chronic disease 
care, as well as information about the characteristics of their service and organisational 
infrastructure.  
The Australian Government and the AIHW have worked with the states and territories to 
develop a national Key Performance Indicator framework for Indigenous primary 
health-care services. The new national KPIs, which replaced the HfL program from June 
2012, cover maternal and child health, and chronic disease management.   
National Key Performance Indicators data  
The national Key Performance Indicators (nKPIs) data collection collects data from primary 
health-care organisations (Aboriginal Community Controlled as well as those with other 
governance arrangements) that receive funding from the Australian Government 
Department of Health to provide services primarily to Aboriginal and Torres Strait Islander 
people. These data are collected and reported to health organisations to help improve the 
delivery of primary health care for Aboriginal and Torres Strait Islander people, to improve 
health outcomes and to support progress towards the Council of Australian Governments’ 
Closing the Gap targets. 
The 19 indicators focus on chronic disease prevention and management and on maternal and 
child health. (Additional indicators are to be added progressively in the future.) These are 
the two key focus areas to achieve the objective of closing the gap in life expectancy between 
Indigenous and non-Indigenous Australians. 
The population of interest in the nKPIs is the regular client population of those primary 
health-care organisations that are required to report against the nKPIs. A regular client is 
defined as a person who has an active medical record—that is, a client who attended the 
primary health-care organisation at least 3 times in the last 2 years. This definition, while 
nationally consistent and in line with the Royal Australian College of General Practitioners’ 
definition of a patient with an active medical record, has limitations, including clients who 
attend multiple health organisations. 
Population data 
Measuring the size of the Indigenous population is not straightforward. The Census count of 
the number of Aboriginal and Torres Strait Islander Australians has varied considerably over 
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recent decades. Analysis of the size of the increases between censuses demonstrates that 
these changes are not entirely due to demographic factors such as births, deaths and 
migration. Instead, they are also in part due to changes in propensity to identify as 
Aboriginal or Torres Strait Islander and improved enumeration (ABS 2013b). 
To calculate the Indigenous and non-Indigenous rates presented in this paper, Estimated 
Resident Population data, as sourced from the ABS, have been used. The Indigenous 
population estimates and projections used in this paper are based on the 2006 Census (Series 
B) (ABS 2009), with the exception of mortality trends over time which have used the recently 
released Indigenous population estimates and projections based on the 2011 Census (Series 
B) (ABS 2014).  
The Census count of the Indigenous population is based on responses to a question on a 
person’s Indigenous status. The Indigenous Estimated Resident Population is computed 
using this count, adjusted for undercount (based on results from the Post Enumeration 
Survey as well as for non-response to the Indigenous status question). Population numbers 
for years other than Census years are projected based on assumed future levels of fertility, 
mortality and migration (ABS 2009).  
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Appendix B: Technical information  
Appendix B presents information on how the statistics in this paper were calculated, and 
other technical points. 
Age-specific rates 
An ‘age-specific rate’ is defined as the number of events for a specified age group over a 
specified period (for example, a year) divided by the total population at risk of the event in 
that age group. Age-specific rates in this paper were calculated by dividing, for example, the 
number of deaths in each specified age group by the corresponding population in the same 
age group. 
Age-standardised rates 
Age-standardised rates enable comparisons to be made between populations that have 
different age structures, such as the Indigenous and non-Indigenous populations.  
In this paper, age-standardised rates have been directly age-standardised using the 30 June 
2001 estimated resident population in Australia as the standard population, using 5-year age 
groups from 0–4 to 75 and over. This effectively removes the influence of the age structure 
on the summary rate.  
Crude rates 
A ‘crude rate’ is defined as the number of events (for example, deaths of Indigenous people) 
over a specified period (for example, a year) divided by the total population at risk of the 
event (for example, number of Indigenous people).  
Rate difference 
For this paper, rate differences were calculated by subtracting the age-standardised rate for 
non-Indigenous Australians from the age-standardised rate for Indigenous Australians for 
the characteristic of interest.  
Rate ratio 
For this paper, rate ratios were calculated by dividing the age-standardised rate for 
Indigenous Australians by the age-standardised rate for non-Indigenous Australians for the 
characteristic of interest.  
A rate ratio of 1 indicates that the prevalence of the characteristic is the same in the 
Indigenous and non-Indigenous populations. Rate ratios that are greater than 1 indicate 
higher prevalence in the Indigenous population and rate ratios less than 1 indicate higher 
prevalence in the non-Indigenous population. 
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Appendix C: Additional tables 
Table C2.1: Prevalence of selected behavioural and biomedical risk factors among Indigenous 
Australians aged 15 and over, by age, 2012–13 (per cent) 
 Age group (years) 
Risk factor 15–17 18–34 35–54 55 and over 
Current daily smoker 17.6 47.1 46.8 26.2 
Overweight/obese 36.3 60.4 75.3 77.3 
High blood pressure n.a. 9.8 27.2 36.5 
High cholesterol (self-reported) n.p. n.p. 3.9 7.3 
n.a. not available 
n.p.    not publishable because of small numbers, confidentiality or other concerns about the quality of the data 
Source: ABS 2013a. 
 
Table C2.2: Prevalence of Indigenous current daily smokers aged 18 and over, (selected years) 
 2001 2004–05 2008 2012–13 
Per cent  50.7 50.0 47.7 43.8 
Note: Data for 2008 are from the ABS National Aboriginal and Torres Strait Islander Social Survey. 
Source: ABS 2013a. 
 
Table C2.3: Age-specific hospitalisation rates for a principal diagnosis of coronary heart disease, by 
Indigenous status, July 2010 to June 2012 (hospitalisations per 1,000 population) 
Age group (years) Indigenous Non-Indigenous 
0–24 0.0 0.0 
25–34 2.0 0.2 
35–44 10.2 1.5 
45–54 25.0 5.6 
55–64 36.2 12.9 
65 and over 42.5 29.6 
Note: Age-specific rates for Indigenous hospitalisations are calculated using population projections based on the 2006 Census (series B). 
Source: AIHW National Hospital Morbidity Database. 
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Table C2.4: Age-standardised CHD hospitalisation rates, by Indigenous status and sex, NSW, Vic, 
Qld, WA, SA and NT combined, 2004–05 to 2011–12 (hospitalisations per 1,000 population) 
 Males  Females 
 Indigenous Non-Indigenous  Indigenous Non-Indigenous  
2004–05 16.7 10.3  11.9 4.7 
2005–06 16.7 10.3  11.9 4.6 
2006–07 16.5 10.0  12.3 4.4 
2007–08 17.9 9.7  12.5 4.3 
2008–09 17.5 9.0  12.4 4.0 
2009–10 16.7 8.7  11.8 3.9 
2010–11  17.1 8.6  11.7 3.8 
2011–12 18.0 8.4  11.8 3.6 
Note:  Rates have been directly age standardised to the 2001 Australian Estimated Resident Population. 
Source: AIHW National Hospital Morbidity Database. 
 
Table C2.5: Use of coronary procedures during hospitalisations for CHD, by Indigenous status, 
July 2010 to June 2012 (per cent) 
Procedure Indigenous Non-Indigenous 
Coronary angiography 32.4 52.0 
Revascularisation (PCI & CABG) 19.0 29.9 
Percutaneous coronary intervention (PCI) 12.9 23.3 
Coronary artery bypass graft (CABG) 6.1 6.6 
Note: Indigenous rates were age-standardised using the age-specific rates of non-Indigenous Australians. 
Source: AIHW National Hospital Morbidity Database. 
 
Table C2.6: Indigenous and non-Indigenous deaths from CHD, by age, NSW, Qld, WA, SA and NT 
combined, 2007–2011 (per cent) 
Age group (years) Indigenous Non-Indigenous 
0–24 0.3 0.0 
25–34 4.1 0.2 
35–44 14.8 1.0 
45–54 22.6 3.3 
55–64 21.3 7.2 
65–74  17.6 12.6 
75 and over 19.3 75.7 
Total 100.0 100.0 
Note: Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
Source: AIHW National Mortality Database. 
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Table C2.7: Age-specific CHD death rates, by Indigenous status and sex, NSW, QLD, WA, SA and 
NT combined, 2007–2011 (number per 100,000 population) 
 Males  Females 
Age group (years) Indigenous Non-Indigenous   Indigenous  Non-Indigenous  
0–24 0.4 0.1  0.3 0.1 
25–34 27.5 2.7  10.5 0.4 
35–44 116.97 12.0  41.5 2.0 
45–54 248.1 41.5  83.4 8.6 
55–64 371.6 103.0  174.7 25.6 
65–74  658.9 263.0  386.2 98.1 
75 and over 1,526.2 1,366.0  1,118.5 1,138.3 
Note: Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
Source: AIHW National Mortality Database. 
 
Table C2.8: Age-standardised CHD death rates, by Indigenous status and sex, NSW, QLD, WA, SA 
and NT combined, 2001 to 2011 (deaths per 100,000 population) 
 Males  Females 
 Indigenous Non-Indigenous  Indigenous Non-Indigenous 
2001 284.5 164.7  167.6 107.1 
2002 263.3 159.5  167.1 102.9 
2003 227.6 153.9  145.4 98.0 
2004 249.0 146.9  151.0 95.3 
2005 196.2 133.8  130.7 88.9 
2006 195.0 130.7  134.1 85.0 
2007 194.8 125.4  132.3 81.2 
2008 177.3 125.5  115.3 85.8 
2009 200.3 115.2  128.8 76.5 
2010 197.1 109.9  88.2 72.9 
2011 193.6 107.9  100.0 70.7 
Average annual change(a) –8.6* –5.9*  –7.0* –3.6* 
Per cent change over period(b) –30.2* –35.8*  –41.9* –33.4* 
* Represents results with statistically significant increases or decreases at the p<.05 level over the period 2001 to 2011. 
(a) Average annual change in rates determined using linear regression analyses. 
(b) Percent change between 2001 and 2011 based on the average annual change over the period. 
Notes 
1. Rates have been age-standardised to the 2001 Australian Estimated Resident population.  
2. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
Source: AIHW National Mortality Database. 
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Table C3.1: Age-standardised rates of Australians reporting COPD, by Indigenous status and sex, 
2012–13 (per cent) 
 Males Females Persons 
Indigenous 4.7 6.0 5.4 
Non-Indigenous  2.0 2.3 2.2 
Notes 
1. Rates have been age-standardised to the 2001 Australian Estimated Resident population. 
2.  Data for non-Indigenous people are for 2011–12, from the Australian Health Survey 2011–13. 
Source: ABS 2013a. 
 
Table C3.2: Age-specific hospitalisation rates for a principal diagnosis of COPD, by Indigenous 
status, July 2010 to June 2012 (number per 1,000 population) 
Age group (years) Indigenous Non-Indigenous 
0–24 0.1 0.0 
25–34 0.8 0.1 
35–44 4.3 0.3 
45–54 12.4 1.1 
55–64 27.7 3.6 
65 and over 58.4 14.9 
Note: Age-specific rates for Indigenous hospitalisations are calculated using population projections based on the 2006 Census (series B). 
Source: AIHW National Hospital Morbidity Database. 
 
  
 40 Coronary heart disease and chronic obstructive pulmonary disease in Indigenous Australians 
Table C3.3: Age-standardised hospitalisation rates for COPD, by Indigenous status and sex, NSW, 
Vic, Qld, WA, SA and NT combined, 2004–05 to 2011–12 (hospitalisations per 1,000 population) 
 Males  Females 
 Indigenous Non-Indigenous  Indigenous Non-Indigenous 
2004–05 13.5 3.3  10.7 2.0 
2005–06 13.3 3.2  11.3 2.1 
2006–07 11.0 3.0  10.5 2.0 
2007–08 12.6 3.1  12.2 2.1 
2008–09 11.8 3.0  12.2 2.2 
2009–10 11.5 2.8  12.0 2.0 
2010–11  12.3 2.9  13.0 2.1 
2011–12 13.6 2.9  13.5 2.1 
Average annual change(a) –0.4 –0.1*  0.4* 0.0 
Per cent change over period(b) –2.2 –12.6*  25.4* 3.3 
* Represents results with statistically significant increases or decreases at the p<.05 level over the period 2004–05 to 2011–12. 
(a) Average annual change in rates determined using linear regression analyses. 
(b) Percent change between 2001 and 2011 based on the average annual change over the period. 
Note: Rates have been age-standardised to the 2001 Australian Estimated Resident population. 
Source: AIHW National Hospital Morbidity Database. 
 
Table C3.4: Indigenous and non-Indigenous deaths from COPD, by age, NSW, Qld, WA, SA and 
NT combined, 2007–2011 (per cent) 
Age group (years) Indigenous Non-Indigenous 
0–24 0.7 0.1 
25–34 0.2 0.0 
35–44 2.0 0.2 
45–54 10.4 1.5 
55–64 24.7 7.1 
65–74  30.5 20.1 
75 and over 31.4 71.1 
Total 100.0 100.0 
Note: Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
Source: AIHW National Mortality Database. 
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Table C3.5: Age-specific death rates of COPD, by Indigenous status and sex, NSW, Qld, WA, SA 
and NT combined, 2007–2011 (deaths per 100,000 population) 
 Males  Females 
Age group (years) Indigenous Non-Indigenous  Indigenous Non-Indigenous 
0–24 0.3 0.1  0.2 0.0 
25–34 0.6 0.1  0.0 0.0 
35–44 4.1 0.4  1.9 0.2 
45–54 20.7 2.6  20.6 2.5 
55–64 87.1 16.4  84.4 13.3 
65–74  272.5 81.0  220.7 52.9 
75 and over 773.7 363.1  450.1 205.8 
Note: Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
Source: AIHW National Mortality Database. 
 
Table C3.6: Age-standardised COPD death rates, by Indigenous status and sex, NSW, QLD, WA, 
SA and NT combined, 2001 to 2011 (deaths per 100,000 population) 
 Males  Females 
 Indigenous  Non-Indigenous   Indigenous  Non-Indigenous  
2001 102.2 36.1  51.4 17.7 
2002 84.8 38.3  36.5 19.0 
2003 66.4 35.2  48.0 18.1 
2004 57.9 31.9  56.6 18.4 
2005 58.6 30.2  47.1 16.1 
2006 89.6 28.3  55.6 15.9 
2007 65.4 29.3  46.3 16.4 
2008 68.9 30.0  37.4 17.7 
2009 56.8 28.3  52.8 16.6 
2010 56.9 28.0  51.3 17.6 
2011 76.3 29.7  45.8 18.4 
Average annual change(a) –2.1 –0.9*  0.1 –0.1 
Per cent change over period(b) –21.4 –24.7*  1.1 –4.0 
* Represents results with statistically significant increases or decreases at the p<.05 level over the period 2001 to 2011. 
(a) Average annual change in rates determined using linear regression analyses. 
(b) Percent change between 2001 and 2011 based on the average annual change over the period. 
Notes 
1. Rates have been age-standardised to the 2001 Australian Estimated Resident population.  
2. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
Source: AIHW National Mortality Database. 
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Table C3.7: COPD and lung cancer mortality, by Indigenous status, 2001 to 2011 (deaths per 100,000 
population) 
 COPD  Lung cancer 
 Indigenous  Non-Indigenous   Indigenous  Non-Indigenous  
2001 74.2 25.3  50.0 35.4 
2002 58.0 27.1  47.5 36.3 
2003 55.7 25.3  50.0 33.4 
2004 57.5 24.0  47.2 35.2 
2005 51.9 22.1  46.4 35.0 
2006 70.2 21.1  49.1 33.5 
2007 54.1 22.0  56.1 33.5 
2008 50.5 23.0  50.6 34.5 
2009 54.2 21.6  51.8 33.4 
2010 53.8 22.1  52.7 34.3 
2011 57.9 23.3  60.4 32.8 
Average annual change(a) –1.0 –0.4*  0.9* –0.2* 
Per cent change over period(b) –14.1 –15.5*  17.2* –6.1* 
* Represents results with statistically significant increases or decreases at the p<.05 level over the period 2001 to 2011. 
(a) Average annual change in rates determined using linear regression analyses. 
(b) Percent change between 2001 and 2011 based on the average annual change over the period. 
Notes 
1. Rates have been age-standardised to the 2001 Australian Estimated Resident population.  
2. Cause-of-death data for 2010 and 2011 are revised and preliminary, respectively, and subject to revision by the ABS. 
Source: AIHW National Mortality Database. 
 
Table C4.1: MBS health checks for Indigenous Australians, by age, 2006–07 to 2011–12 (number per 
1,000 population) 
 0–14 years 15–54 years 55 years and over 
2006–07 32.5 44.5 84.6 
2007–08 63.5 53.1 98.6 
2008–09 72.2 60.6 115.4 
2009–10 87.9 74.5 137.5 
2010–11  112.5 120.0 209.4 
2011–12 154.2 158.4 256.3 
Source: AIHW forthcoming. 
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Table C4.2: Indigenous clients with CHD with a General Practitioner Management Plan and a 
Team Care Arrangement, 2007–08 to 2010–11 (number) 
 General Practitioner Management Plan Team Care Arrangement 
2007–08 405 215 
2008–09 359 242 
2009–10 488 337 
2010–11  750 453 
Source: AIHW 2013b. 
 
Table C4.3: Indigenous clients with CHD who had a blood pressure test in the last 6 months and 
whose blood pressure was less than 140/90 mmHg, 2007–08 to 2010–11 (number) 
 2007–08 2008–09 2009–10 2010–11 
Clients with CHD who had a blood pressure test in the last 6 months 1,312 1,222 1,485 1,523 
Clients who had a blood pressure result of less than 140/90 mmHg 800 772 851 n.a. 
n.a.  not available. 
Source: AIHW 2013b. 
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Coronary heart disease and 
chronic obstructive pulmonary disease 
in Indigenous Australians
The pattern of coronary heart disease and chronic obstructive 
pulmonary disease in Indigenous Australians differs to 
that in non-Indigenous Australians. This paper shows that 
Indigenous Australians have higher hospitalisation and death 
rates for these conditions than non-Indigenous Australians, 
and are more likely to die from these conditions at younger 
ages. However there are some encouraging trends seen in 
the Indigenous population, such as declining death rates 
from coronary heart disease, improved chronic disease 
management and declining smoking rates.
